Better Coronavirus Stock: Inovio Pharmaceuticals or Regeneron?

Better Coronavirus Stock: Inovio Pharmaceuticals or Regeneron?

Motley Fool

Published

Which stock wins in a battle between these two biotechs with promising COVID-19 programs?

Full Article